PolyQuant is a company providing ISO 9001:2015 certified products, services, and bioinformatics support for protein analysis and proteomics. Their offerings include stable isotope-labelled reference standards for absolute protein quantification based on the proprietary QconCAT platform technology, stable isotope-labelled full-length proteins, kits for LC and MS instrument calibration and standardization, ready-to-use QconCAT kits, as well as entire assay development for proteomics workflows (quantitative/qualitative) and comprehensive support for protein analytics within the Medtech, Biotech, Life Sciences, and Pharma industries. The proprietary QconCAT technology enables multiplex absolute quantification of tens to several hundreds of proteins in a single mass spectrometry experiment and proves to be a valuable tool for various proteomics projects involving absolute protein quantification, such as biomarker research and validation, MS-based in vitro diagnostics, protein analytics, quality control, and host-cell-protein analysis. Based in Germany, PolyQuant's focus on providing cutting-edge products and services for protein analysis and proteomics demonstrates their commitment to addressing the evolving needs of the life sciences industry. Despite the absence of specific founding and investment details, the company's dedication to delivering innovative solutions in the realm of protein quantification and analytics positions them as a promising player within the biotech and medtech sectors.
There is no investment information
No recent news or press coverage available for PolyQuant.